Transcriptional profiling of breast cancer cells exposed to soy phytoestrogens after brca1 knockdown with a whole human genome microarray approach

Nutrition and Cancer

Volumn 62, Issue 5, 2010, Pages 659-667

  Satih, Samir ^a,b,c   Chalabi, Nasséra ^a,b,c   Rabiau, Nadége ^a,b,c,d   Bignon, Yves Jean ^a,b,c   Bernard Gallon, Dominique J ^a,b,c  

^a CENTRE JEAN PERRIN   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d Soluscience Biopôle Clermont Limagne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DAIDZEIN; DOUBLE STRANDED RNA; ESTROGEN RECEPTOR; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 13; PHYTOESTROGEN; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; BAX PROTEIN, HUMAN; ISOFLAVONE DERIVATIVE; PTPN13 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL COMMUNICATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN GENOME; KNOCKOUT MOUSE; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SOYBEAN; STEROL METABOLISM; XENOBIOTIC METABOLISM; BREAST NEOPLASMS; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; PROCEDURES; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, BRCA1; HUMANS; ISOFLAVONES; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER;

EID: 77953992759     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605540     Document Type: Article

References (48)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71, 1994. (Pubitemid 24345325)
2. Schubert EL, MeffordHC, Dann JL,Argonza RH, Hull J, et al.: BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Genet Test 1, 41-46, 1997.
3. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, et al.: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21, 236-240, 1999.
4. Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, et al.: Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci USA 99, 827-831, 2002.
5. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, et al.: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92, 564-569, 2000.
6. Keinan-Boker L, Van Der Schouw YT, Grobbee DE, and Peeters PH: Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79, 282-288, 2004.
7. Shu XO, Jin F, Dai Q, Wen W, Potter JD, et al.: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10, 483-488, 2001. (Pubitemid 32701634)
8. Hilakivi-Clarke L, Clarke R, and Lippman M: The influence of maternal diet on breast cancer risk among female offspring. Nutrition 15, 392-401, 1999.
9. Seo HS, DeNardo DG, Jacquot Y, Laios I, Vidal DS, et al.: Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 99, 121-134, 2006.
10. Allred CD, Ju YH, Allred KF, Chang J, and Helferich WG: Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22, 1667-1673, 2001.
11. De Assis S and Hilakivi-Clarke L: Timing of dietary estrogenic exposures and breast cancer risk. Ann NY Acad Sci 1089, 14-35, 2006.
12. Lamartiniere CA: Timing of exposure and mammary cancer risk. J Mammary Gland Biol Neoplasia 7, 67-76, 2002.
13. Soule HD, Vazguez J, Long A, Albert S, and BrennanM: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51, 1409-1416, 1973.
14. Cailleau R, Young R, Olive M, and Reeves WJ Jr: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53, 661-674, 1974.
15. Soule HD, Maloney TM,Wolman SR, PetersonWD Jr., Brenz R, et al.: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6075-6086, 1990.
16. Satih S, Chalabi N, Delort L, Le Corre L, Rabiau N, et al.: BRCA1 specific knockdown by RNA interference in human tumor breast cell lines. In: New Approaches inNutrition and Cancer, Bernard-GallonDJ (ed.). Trivandrum, Kerala, India: Transworld Research Network, 2006, pp. 81-94.
17. Vissac-Sabatier C, Bignon Y-J, and Bernard-Gallon DJ: Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr Cancer 45, 247-255, 2003.
18. Wettenhall JM and Smyth GK: limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20, 3705-3706, 2004.
19. Edwards D: Non-linear normalization and background correction in onechannel cDNA microarray studies. Bioinformatics 19, 825-833, 2003.
20. Hosack DA, Dennis G Jr., Sherman BT, Lane HC, and Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol 4, R70, 2003.
21. Rice S and Whitehead SA: Phytoestrogens oestrogen synthesis and breast cancer. J Steroid Biochem Mol Biol 108, 186-195, 2008.
22. Yager JD and Liehr JG: Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36, 203-232, 1996.
23. Fan S,Ma YX,Wang C, Yuan RQ,Meng Q, et al.: Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20, 77-87, 2001.
24. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, et al.: Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85, 1819-1827, 1993.
25. Trock BJ, Hilakivi-Clarke L, and Clarke R: Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459-471, 2006.
26. Wu AH, Koh WP, Wang R, Lee HP, and Yu MC: Soy intake and breast cancer risk in Singapore Chinese Health Study. Br J Cancer 99, 196-200, 2008.
27. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, et al.: Population-based casecontrol study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85, 372-378, 2001. (Pubitemid 32747705)
28. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, et al.: Dietary effects on breast-cancer risk in Singapore. Lancet 337, 1197-1200, 1991.
29. Messina M, Nagata C, and Wu AH: Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1-12, 2006.
30. Manach C,Williamson G,Morand C, Scalbert A, and Remesy C: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 Suppl.), 230S-242S, 2005.
31. MiltykW, Craciunescu CN, Fischer L, Jeffcoat RA, Koch MA, et al.: Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer. Am J Clin Nutr 77, 875-882, 2003.
32. Frey RS and Singletary KW: Genistein activates p38 mitogen-activated protein kinase, inactivates ERK1/ERK2 and decreases Cdc25C expression in immortalized human mammary epithelial cells. J Nutr 133, 226-231, 2003.
33. Frey RS, Li J, and Singletary KW: Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21(waf/cip1), p27(kip1), and Cdc25C expression. Biochem Pharmacol 61, 979-989, 2001.
34. Martin KJ, Kritzman BM, Price LM, Koh B, Kwan CP, et al.: Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 60, 2232-2238, 2000.
35. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, et al.: Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 9, 2981-2991, 2000.
36. Lee HJ,Wang CJ, Kuo HC, Chou FP, Jean LF, et al.: Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharmacol 203, 124-131, 2005.
37. Xu J and Loo G: Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines. J Cell Biochem 82, 78-88, 2001.
38. Ramos S: Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18, 427-442, 2007.
39. Li Y, Upadhyay S, Bhuiyan M, and Sarkar FH: Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18, 3166-3172, 1999. (Pubitemid 29261238)
40. Li S, Jin Y, Wang H, and Li Y: [Role of apoptosis and bcl-2 gene in the temporomandibular joint development]. Hua Xi Kou Qiang Yi Xue Za Zhi 17, 205-207, 1999.
41. Caetano B, Le Corre L, Chalabi N, Delort L, Bignon YJ, et al.: Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines. Br J Nutr 95, 406-413, 2006.
42. Tominaga Y,Wang A,Wang RH,Wang X, Cao L, et al.: Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe. Cell Death Differ 14, 472-479, 2007.
43. Oltvai ZN, Milliman CL, and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619, 1993.
44. Benezra M, Chevallier N, Morrison DJ, MacLachlan TK, El-Deiry WS, et al.:BRCA1augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit. J Biol Chem 278, 26333-26341, 2003.
45. Divya CS and Pillai MR: Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 45, 320-332, 2006.
46. Biswas DK, Singh S, Shi Q, Pardee AB, and Iglehart JD: Crossroads of estrogen receptor and NF-kappaB signaling. Sci STKE 2005, pe27, 2005.
47. Rubio MF, Werbajh S, Cafferata EG, Quaglino A, Colo GP, et al.: TNFalpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25, 1367-1377, 2006.
48. Freiss G, Bompard G, and Vignon F: [PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers]. Bull Cancer 91, 325-332, 2004.